Der Onkologe

, Volume 18, Issue 6, pp 543–544 | Cite as

Chemotherapie bei Magenkarzinom

Zweite Linie sinnvoll
Journal Club

Chemotherapy for stomach cancer

Second line makes sense


  1. 1.
    Siegel R, Naishadham D, Jemal A (2002) Cancer statistics. CA Cancer J Clin 62:10–29CrossRefGoogle Scholar
  2. 2.
    Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150PubMedCrossRefGoogle Scholar
  3. 3.
    Wagner AD et al (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 24:2903–2909PubMedCrossRefGoogle Scholar
  4. 4.
    Temel JS et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMedCrossRefGoogle Scholar
  5. 5.
    Thuss-Patience PC et al (2011) Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer—a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Eur J Cancer 47:2306–2314PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Medizinische Klinik III (Hämatologie und Onkologie)Klinikum BraunschweigBraunschweigDeutschland

Personalised recommendations